Abstract
In consultation the authors were requested to evaluate a middle-aged diabetic woman for an apparent episode of biliary sepsis. The patient had been admitted to the dermatology service with a four-day history of rash and pruritus. This was initially thought to represent an allergic reaction to dicloxacillin in someone with a previous history of penicillin hypersensitivity. Persistent right upper quadrant pain, fevers, elevations of serum alkaline phosphatase, and a radionuclide scan which did not demonstrate a functioning gall bladder led to a cholecystectomy for acute cholecystitis and possible biliary sepsis. This diagnosis was not confirmed. Ultimately, this case illustrated the need to review carefully recent changes in any patient's drug regimen. Reactions to commonly prescribed agents may cause syndromes which are difficult to distinguish from episodes of apparent sepsis.
Full text
PDF
Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- BROWN G., ZOIDIS J., SPRING M. Hepatic damage during chlorpropamide therapy. J Am Med Assoc. 1959 Aug 22;170(17):2085–2088. doi: 10.1001/jama.1959.63010170005010b. [DOI] [PubMed] [Google Scholar]
- HAMFF L. H., FERRIS H. A., EVANS E. C., WHITEMAN H. W. The effects of tolbutamide and chlorpropamide on patients exhibiting jaundice as a result of previous chlorpropamide therapy. Ann N Y Acad Sci. 1959 Mar 30;74(3):820–829. doi: 10.1111/j.1749-6632.1959.tb39611.x. [DOI] [PubMed] [Google Scholar]
- Kreisberg R. A. The second-generation sulfonylureas: change or progress? Ann Intern Med. 1985 Jan;102(1):125–126. doi: 10.7326/0003-4819-102-1-125. [DOI] [PubMed] [Google Scholar]
- REICHEL J., GOLDBERG S. B., ELLENBERG M., SCHAFFNER F. Intrahepatic cholestasis following administration of chlorpropamide. Report of a case with electron microscopic observations. Am J Med. 1960 Apr;28:654–660. doi: 10.1016/0002-9343(60)90161-3. [DOI] [PubMed] [Google Scholar]
- Shen S. W., Bressler R. Clinical pharmacology of oral antidiabetic agents (first of two parts). N Engl J Med. 1977 Mar 3;296(9):493–497. doi: 10.1056/NEJM197703032960906. [DOI] [PubMed] [Google Scholar]
- Shen S. W., Bressler R. Clinical pharmacology of oral antidiabetic agents (second of two parts). N Engl J Med. 1977 Apr 7;296(14):787–793. doi: 10.1056/NEJM197704072961405. [DOI] [PubMed] [Google Scholar]
- Shuman C. R. Glipizide: an overview. Am J Med. 1983 Nov 30;75(5B):55–59. doi: 10.1016/0002-9343(83)90254-1. [DOI] [PubMed] [Google Scholar]
- Skillman T. G., Feldman J. M. The pharmacology of sulfonylureas. Am J Med. 1981 Feb;70(2):361–372. doi: 10.1016/0002-9343(81)90773-7. [DOI] [PubMed] [Google Scholar]
- Wongpaitoon V., Mills P. R., Russell R. I., Patrick R. S. Intrahepatic cholestasis and cutaneous bullae associated with glibenclamide therapy. Postgrad Med J. 1981 Apr;57(666):244–246. doi: 10.1136/pgmj.57.666.244. [DOI] [PMC free article] [PubMed] [Google Scholar]